Brain Attack! ‘26

Brain Attack! ‘26 is organized by David Geffen School of Medicine at University of California, Los Angeles (UCLA) and will be held on Oct 10, 2026 at UCLA Carnesale Commons Palisades Ballroom, Los Angeles, California, United States of America.

Overview:
Symposium on State-of-the-Art Stroke Management

Presented by the UCLA Comprehensive Stroke Center, UCLA Brain Attack! ’26 is a premier, multidisciplinary symposium designed for clinicians and partners committed to advancing excellence across the stroke care continuum.

Stroke remains a leading cause of death and long-term disability in the United States, even as rapid advances in prevention, diagnostics, and intervention continue to reshape clinical practice. Brain Attack! ’26 translates this evolving evidence into practical, real-world clinical strategies, focusing on areas where practice variability and implementation challenges persist.

Through expert-led presentations, case-based discussions, and multidisciplinary perspectives, participants will engage with the latest data shaping modern stroke care—including advanced neuroimaging, expanded reperfusion strategies, intracerebral hemorrhage management, and evolving approaches to neurovascular disease and recovery.

Why This Program Matters:
Recent trials and guideline updates have expanded indications for intravenous thrombolysis and endovascular thrombectomy well beyond traditional time windows, while innovations in imaging, anticoagulation, and device-based therapies continue to accelerate. At the same time, clinicians and healthcare systems face increasing complexity in patient selection, workflow design, and coordinated care delivery.

UCLA Brain Attack! ’26 is designed to meet this moment—bridging the gap between evidence and practice by equipping healthcare professionals with the clinical reasoning frameworks needed to navigate complex and time-sensitive decisions across diverse care settings.

Objectives:
At the conclusion of this activity, learners will be able to:

1. Apply neuroimaging strategies, including advanced and simplified imaging paradigms, to support diagnostic evaluation and treatment decision-making in ischemic and hemorrhagic stroke.
2. Analyze current clinical trial evidence and guideline recommendations supporting acute ischemic stroke therapies, including intravenous thrombolytics, expanded treatment windows, and endovascular thrombectomy.
3. Select evidence-based medical, endovascular, or surgical management approaches for intracerebral hemorrhage, subdural hematoma, and cerebral aneurysms based on patient characteristics and disease severity.
4. Interpret evolving evidence related to stroke recovery, rehabilitation, and systems of care to inform multidisciplinary care planning across the stroke continuum.